Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Pediatric NF1 with Plexiform Neurofibromas
NCT02177825Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Jun 2014
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in plexiform neurofibroma (PN), sponsored by Centre Hospitalier Universitaire Sainte-Justine. Started Jun 2014; status: terminated.
02
Drugs
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT02177825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177825.